NasdaqCM:ASRTPharmaceuticals
Assertio Holdings (ASRT) Q4 Loss Of US$11.9 Million Reinforces Ongoing Bearish Earnings Narrative
Assertio Holdings (ASRT) closed out FY 2025 with Q4 revenue of US$13.5 million and basic EPS of a US$1.86 loss, alongside a trailing twelve month revenue base of US$118.7 million and basic EPS of a US$4.74 loss. Over the past year, quarterly revenue has moved between US$26.5 million and US$49.5 million, while quarterly basic EPS has ranged from a US$2.56 loss to US$1.78, leaving investors focused on how these shifts are feeding through to underlying margins.
See our full analysis for Assertio...